Altered Antibiotic Pharmacokinetics during Extracorporeal Membrane Oxygenation may Cause Therapeutic Failure - 28/07/12
Doi : 10.1016/j.hlc.2012.05.581
K. Shekar 1, 2, ⁎, S. Diab 1, C. Mcdonald 1, 2, S. Fisquet 1, K. Dunster 1, 3, L. Fung 1, 2, D. Platts 1, 2, S. Ghassabian 4, A. Barnett 5, J. Roberts 6, M. Smith 4, 7, J. Fraser 1, 2
1 Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD 4032, Australia
2 The University of Queensland, Brisbane, QLD, Australia
3 Queensland University of Technology, Brisbane, QLD, Australia
4 Centre for Integrated Preclinical Drug Development, The University of Queensland, St Lucia Campus, Brisbane, QLD 4072, Australia
5 Institute of Health and Biomedical Innovation & School of Public Health, Queensland University of Technology, Australia
6 Burns Trauma and Critical Care Research Centre, The University of Queensland Queensland, Australia
7 School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia
Corresponding author.
Le texte complet de cet article est disponible en PDF.
© 2012
Publié par Elsevier Masson SAS.
Vol 21 - N° S1
P. S235-S236 - 2012 Retour au numéro
Article précédent
- 12-Lead ECG Screening in Elite Athletes – An Initial Australian Experience
- G. King, M. Dwan, V. Manins, R. Pascoe
- CPR-ECMO for In-Hospital Cardiac Arrest: What are the Predictive Factors for Survival and are We Missing Anyone?
- S. Andvik, C. Soto, A. Jackson, R. Pye, M. Nichols, G. Fulde, E. Granger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?